Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trialJean‐Michel Molina, Juergen Rockstroh, Ming‐Tain Lai et al.|The Lancet HIV|2018Cited by 145
Preclinical Studies of OBI-999: A Novel Globo H–Targeting Antibody–Drug ConjugateMing-Chen Yang, Ming‐Tain Lai|Molecular Cancer Therapeutics|2021Cited by 30
Mechanistic Study of Common Non-Nucleoside Reverse Transcriptase Inhibitor-Resistant Mutations with K103N and Y181C SubstitutionsMing‐Tain Lai, Michael D. Miller|Viruses|2016Cited by 18